- Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report
-
Kang SJ, Lee R, Kim HS
- KMID: 2447379
- Ann Pediatr Endocrinol Metab.
- 2019 Mar;24(1):64-67.
- doi: 10.6065/apem.2019.24.1.64
Idiopathic infantile hypercalcemia is characterized by hypercalcemia, dehydration, vomiting, and failure to thrive, and it is due to mutations in 24-hydroxylase (CYP24A1). Recently, mutations in sodium-phosphate cotransporter (SLC34A1) expressed in... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of circulating 25-hydroxyvitamin D levels with hypertension and blood pressure values in Korean adults: A Mendelian randomization study on a subset of the Korea National Health and Nutrition Survey 2011–2012 population
-
Kwak SY, Cho Y, Oh H, Shin MJ
- KMID: 2464129
- Nutr Res Pract.
- 2019 Dec;13(6):498-508.
- doi: 10.4162/nrp.2019.13.6.498
BACKGROUND/OBJECTIVES: Lower circulating 25-hydroxyvitamin D [25(OH)D] levels are associated with a higher risk of hypertension (HTN); however, it remains unclear whether the relationship is causal. We aimed to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate
-
Jin LH, Kim BH, Lee JH, Lee K, Kwack K, Yim SV
- KMID: 2406997
- Transl Clin Pharmacol.
- 2017 Dec;25(4):166-172.
- doi: 10.12793/tcp.2017.25.4.166
Talniflumate is a phthalidyl ester of niflumic acid, which has potent analgesic and anti-inflammatory effects and is widely used to treat inflammatory disorders, such as rheumatoid arthritis. To screen the... -
- CITED
-
- Close
- SHARE
-
- Close
